GlassScriptPhysician profile
Brian Bruening
NPI 1124020318
$1,785.73
in general payments reported to CMS, 2019-2025
9 companies · $308 in 2025
The $308 reported for 2025 was less than what a typical Vascular & Interventional Radiology provider received nationally (typical 2025 total: $537).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $305 · 2020: $109 · 2021: $503 · 2022: $129 · 2023: $190 · 2024: $242 · 2025: $308.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $740.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $739.90 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tactile Systems Technology INC | $878.63 | 2019-2025 | Flexitouch Plus, Entre Plus, Nimbl |
| Medtronic, INC. | $384.36 | 2021-2025 | Venaseal, Closurefast |
| Inari Medical, INC. | $165.01 | 2021 | |
| Penumbra, INC. | $147.86 | 2021 | |
| Boston Scientific Corporation | $62.58 | 2022 | |
| Cardiva Medical, INC. | $55.77 | 2021 | |
| Medtronic Vascular, INC. | $52.86 | 2019-2020 | |
| Terumo Medical Corporation | $19.92 | 2020 | |
| Angiodynamics, INC. | $18.74 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Bruening listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.